Brookfield Asset Management Ltd. walked away from a plan to acquire Grifols SA, ending months of negotiations to take over the Spanish blood-plasma company. The New York-based money manager said Wednesday it decided to not pursue the deal, confirming a Bloomberg report, after the Grifols board rejected its indicative offer that valued the company at €6.45 billion ($6.8 billion). Brookfield said in a regulatory filing that its decision also comes “after extensive due diligence. Brookfield, whose talks were disclosed publicly in July, was looking to take the company private in partnership with the Grifols family, which owns about a third of the maker of medicines for diseases such as hepatitis and hemophilia.
Read the full article: Brookfield Drops $6.8B Offer to Buy Drugmaker Grifols //
Source: https://finance.yahoo.com/news/brookfield-drops-6-8-billion-125728335.html